azithromycin 40 MG/ML Oral Suspension
azithromycin
RxCUI: 141963
What the CMS Formulary Data Shows for azithromycin 40 MG/ML Oral Suspension
Per the CMS 2026 Part D formulary file, azithromycin 40 MG/ML Oral Suspension (RxNorm concept RXCUI 141963, generic name azithromycin) appears on 321 distinct formulary files spanning 4,964 Medicare Part D plan offerings - 98% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.1.
Real-world access to azithromycin 40 MG/ML Oral Suspension depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 5,970,026 Part D beneficiaries filled azithromycin 40 MG/ML Oral Suspension in 2023, with total plan-and-beneficiary spending of $59,585,357 and an average per-beneficiary annual cost of $9.98. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry azithromycin 40 MG/ML Oral Suspension today.
Coverage Details
- Formularies covering
- 321
- Plans covering
- 4,964
- Coverage rate
- 98%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 5,970,026
- Total spending
- $59,585,357
- Avg per beneficiary
- $9.98
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering azithromycin 40 MG/ML Oral Suspension
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is azithromycin 40 MG/ML Oral Suspension covered by Medicare Part D?
Yes, azithromycin 40 MG/ML Oral Suspension is covered by 4,964 Medicare Part D plans (98% of all Part D formularies).
What tier is azithromycin 40 MG/ML Oral Suspension on Medicare Part D plans?
azithromycin 40 MG/ML Oral Suspension averages Tier 2.1 across Part D plans, ranging from Tier 1 to Tier 4.
Does azithromycin 40 MG/ML Oral Suspension require prior authorization?
0% of Part D formularies require prior authorization for azithromycin 40 MG/ML Oral Suspension. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on azithromycin 40 MG/ML Oral Suspension?
In 2023, total Medicare Part D spending on azithromycin 40 MG/ML Oral Suspension was $59,585,357, covering 5,970,026 beneficiaries. The average spend per beneficiary was $9.98.
Read our methodology - how this data is sourced, computed, and verified.